An ILK/STAT3 pathway controls glioblastoma stem cell plasticity.
Alexander E P Loftus1, Marianna S Romano1, Anh Nguyen Phuong1
1Cancer Research UK Scotland Centre (Edinburgh), Institute of Genetics and Cancer, University of Edinburgh, Crewe Road South, Edinburgh EH4 2XU, UK.
Developmental Cell
|September 26, 2024
Summary
Integrin-linked kinase (ILK) drives glioblastoma stem cell plasticity and invasive behavior by regulating cell state transitions. This ILK/STAT3 pathway is crucial for glioblastoma progression and therapeutic resistance.
Area of Science:
- Cancer Biology
- Neuro-Oncology
- Cellular Signaling
Background:
- Glioblastoma (GBM) is characterized by cellular heterogeneity and phenotypic plasticity, contributing to tumor progression and treatment failure.
- Malignant neural stem-like cells are key drivers of GBM, exhibiting adaptability that complicates therapeutic strategies.
Purpose of the Study:
- To investigate the role of integrin-linked kinase (ILK) in regulating phenotypic plasticity and invasive behavior in glioblastoma stem cells.
- To elucidate the signaling pathways, specifically ILK/STAT3, involved in GBM stem cell state transitions.
Main Methods:
- Utilized a murine glioblastoma stem cell model to study the function of ILK.
- Investigated ILK's role in cell state interconversion and response to transition cues.
- Analyzed the ILK/STAT3 signaling pathway in vitro and in vivo.
- Correlated ILK expression with STAT3-regulated proteins and GBM patient tumor signatures.
Main Results:
- Integrin-linked kinase (ILK) promotes phenotypic plasticity and mesenchymal-like, invasive characteristics in GBM stem cells.
- ILK is essential for the interconversion of GBM stem cells between different malignancy-associated states.
- The ILK/STAT3 signaling pathway governs the transition of GBM stem cells to an astrocyte-like state.
- ILK expression positively correlates with STAT3-regulated proteins and astrocyte-like/mesenchymal signatures in patient tumors.
Conclusions:
- Integrin-linked kinase (ILK) is a critical regulator of glioblastoma stem cell plasticity and mesenchymal phenotypes.
- Targeting ILK may offer a therapeutic strategy to overcome GBM heterogeneity and resistance.
Related Concept Videos
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:20The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
01:29Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
01:19Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K